首页> 外文OA文献 >Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)

【2h】

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)

机译：聚乙二醇化脂质体阿霉素的II期临床试验（CAELYX®/Doxil®）和生活质量评估（EORTC QLQ-C30）晚期软组织肉瘤成年患者的治疗：西班牙肉瘤研究小组（GEIS）的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Pegylated liposomal doxorubicin (PLD), a formulation with pharmacokinetic differences with respectto doxorubicin (DXR), might benefit patients with advanced soft tissue sarcoma (STS) pretreated with DXR.

机译：背景：聚乙二醇脂质体阿霉素（PLD）是一种相对于阿霉素（DXR）具有药代动力学差异的制剂，可能有益于接受DXR治疗的晚期软组织肉瘤（STS）患者。

著录项

作者
Poveda, A.; López-Pousa, A.; Martín, J.; Del Muro, J. García; Bernabé, R.; Casado, A.; Balañá, C.; Sanmartín, O.; Menéndez, M. D.; Escudero, P.; Cruz, J.; Belyakova, Elena; Menéndez, D.; Buesa, J. M.;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献

1. Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX?/Doxil?) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS) [J] . A.Poveda, A.López-Pousa, J.Martín, Sarcoma . 2005,第3a4期

机译：聚乙二醇化脂质体阿霉素（CAELYX？/ Doxil？）II期临床试验和成年晚期软组织肉瘤患者生活质量评估（EORTC QLQ-C30）：西班牙肉瘤研究小组（GEIS）的研究
2. Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS) [J] . A.López-Pousa, J.Martín, J.Montalar, Sarcoma . 2006,第3a4期

机译：成人晚期软组织肉瘤患者中阿霉素加递增剂量的异环磷酰胺Ⅱ期试验：西班牙肉瘤研究小组（GEIS）的研究
3. Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group [J] . D Bafaloukos, C Papadimitriou, H Linardou, British Journal of Cancer . 2004,第9期

机译：聚乙二醇化脂质体阿霉素（PLD）和紫杉醇联合治疗晚期软组织肉瘤：希腊合作肿瘤小组的II期研究
4. Phase II Clinical Trial With Pegylated Liposomal Doxorubicin(CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30)in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS) [O] . A. Poveda, A. López-Pousa, J. Martín, 2005

机译：聚乙二醇化脂质体阿霉素的II期临床试验（CAELYX®/Doxil®）和生活质量评估（EORTC QLQ-C30）晚期软组织肉瘤成年患者的治疗：西班牙肉瘤研究小组（GEIS）的研究
5. Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS) [O] . A. Poveda, A. López-Pousa, J. Martín, 2005

机译：成人高级软组织肉瘤患者使用聚乙二醇化脂质体阿霉素（CaELYX®/Doxil®）和生活质量评估（EORTC QLQ-C30）进行的II期临床试验：西班牙肉瘤研究小组（GEIs）的一项研究

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)

摘要

著录项

相似文献

相关主题

期刊订阅